Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
[Multimodal complex treatment in advanced multiple sclerosis.]
Comments on "Role of intestinal microbiota in the development of multiple sclerosis".
Combined central and peripheral demyelination: A case description.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium).
Ophthalmic manifestations of systemic diseases-part 2: metabolic, infections, granulomatoses, demyelination, and skeletal dysplasias.
Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases.
Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
Targeting the low-hanging fruit of neurodegeneration.
Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia.
Leukotrienes induce the migration of Th17 cells.
Microglia and neuroprotection.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia.
MS Prevalence and Patients' Characteristics in the District of Braga, Portugal.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Neurotoxocarosis alters myelin protein gene transcription and expression.
Acute toxic neuropathy mimicking guillain barre syndrome.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
A spectrum of inflammation and demyelinization in acute disseminated encephalomyelitis (ADEM) of children.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »